ADXN
Price
$8.37
Change
+$0.54 (+6.90%)
Updated
Jul 23, 12:14 PM (EDT)
Capitalization
9.41M
ANVS
Price
$2.65
Change
+$0.08 (+3.11%)
Updated
Jul 23, 04:59 PM (EDT)
Capitalization
50.08M
21 days until earnings call
Interact to see
Advertisement

ADXN vs ANVS

Header iconADXN vs ANVS Comparison
Open Charts ADXN vs ANVSBanner chart's image
Addex Therapeutics
Price$8.37
Change+$0.54 (+6.90%)
Volume$201
Capitalization9.41M
Annovis Bio
Price$2.65
Change+$0.08 (+3.11%)
Volume$1.58K
Capitalization50.08M
ADXN vs ANVS Comparison Chart in %
Loading...
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADXN vs. ANVS commentary
Jul 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Hold and ANVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 24, 2025
Stock price -- (ADXN: $8.12 vs. ANVS: $2.53)
Brand notoriety: ADXN and ANVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 21% vs. ANVS: 48%
Market capitalization -- ADXN: $9.41M vs. ANVS: $50.08M
ADXN [@Biotechnology] is valued at $9.41M. ANVS’s [@Biotechnology] market capitalization is $50.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 2 FA rating(s) are green whileANVS’s FA Score has 1 green FA rating(s).

  • ADXN’s FA Score: 2 green, 3 red.
  • ANVS’s FA Score: 1 green, 4 red.
According to our system of comparison, ADXN is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 6 TA indicator(s) are bullish while ANVS’s TA Score has 4 bullish TA indicator(s).

  • ADXN’s TA Score: 6 bullish, 5 bearish.
  • ANVS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ADXN is a better buy in the short-term than ANVS.

Price Growth

ADXN (@Biotechnology) experienced а -9.79% price change this week, while ANVS (@Biotechnology) price change was -11.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.08%. For the same industry, the average monthly price growth was +21.29%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

ADXN is expected to report earnings on May 15, 2025.

ANVS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANVS($50.1M) has a higher market cap than ADXN($9.41M). ADXN YTD gains are higher at: 15.986 vs. ANVS (-49.702). ADXN has higher annual earnings (EBITDA): -12.19M vs. ANVS (-25.17M). ANVS has more cash in the bank: 22.2M vs. ADXN (3.35M). ADXN has higher revenues than ANVS: ADXN (556K) vs ANVS (0).
ADXNANVSADXN / ANVS
Capitalization9.41M50.1M19%
EBITDA-12.19M-25.17M48%
Gain YTD15.986-49.702-32%
P/E RatioN/AN/A-
Revenue556K0-
Total Cash3.35M22.2M15%
Total Debt43.8KN/A-
TECHNICAL ANALYSIS
Technical Analysis
ADXNANVS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 6 days ago
81%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CACC504.946.15
+1.23%
Credit Acceptance Corp
CTSO1.040.01
+0.97%
Cytosorbents Corp
MA554.651.99
+0.36%
Mastercard
MEC15.330.03
+0.20%
Mayville Engineering Company
OUST29.32-1.33
-4.34%
Ouster Inc

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
+7.68%
ANVS - ADXN
43%
Loosely correlated
-4.53%
CVM - ADXN
39%
Loosely correlated
+9.85%
PHAT - ADXN
28%
Poorly correlated
-1.51%
MOLN - ADXN
27%
Poorly correlated
+7.09%
SGMO - ADXN
26%
Poorly correlated
-3.06%
More

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-4.53%
ADXN - ANVS
43%
Loosely correlated
+7.68%
ATXS - ANVS
39%
Loosely correlated
+4.86%
AMLX - ANVS
39%
Loosely correlated
-1.56%
RXRX - ANVS
38%
Loosely correlated
+9.59%
ERAS - ANVS
37%
Loosely correlated
N/A
More